Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An update from Aptose Biosciences ( (TSE:APS) ) is now available.
Aptose Biosciences Inc., a clinical-stage oncology company, has announced an $8 million public offering of 40 million shares and warrants, priced at $0.20 each, with the participation of existing and new healthcare-focused investors. The proceeds will support the company’s working capital and corporate purposes, and the offering is expected to close by November 25, 2024. A.G.P./Alliance Global Partners is the sole placement agent for this initiative.
For detailed information about APS stock, go to TipRanks’ Stock Analysis page.
Trending Articles
- Nvidia Stock Could Take a Beating from Supply Snags on Blackwell Chips
- ‘This Is Just Pure Hype,’ Says Top Investor About Tesla Stock
- Will Palantir Stock Crash to $28? Jefferies Sounds the Alarm
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
